An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects with Major Depressive Disorder

This study is a multi-center, open-label trial to evaluate the long-term safety and efficacy of AXS-05 in subjects with major depressive disorder (MDD). Eligible subjects must have completed a prior MDD study with AXS-05 (AXS-05-301 or AXS-05-MDD-301) immediately prior to enrollment in this study.

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Depressive Disorder,Depression,Mental Health,Depressed state
• Age: - 99 Years
• Gender: All